Strength
180000; 36000; 114000 [USP'U]/1; [USP'U]/1; [USP'U]/1
Manufacturer
AbbVie Inc.NDC
00032263701
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Last Updated
1/2/2026
Active Ingredients
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASEApproval Type
Biologic (BLA)
FDA Application
BLA020725On Market Since
10/12/2023
Related Drugs
Same classification
No related drugs found.